Efficacy and Safety of Voclosporin Over 3 Years in Patients With Severe Lupus Nephritis

被引：0
|
作者：
Menn-Josephy, Hanni [1 ]
Truman, Matt [2 ]
Palmen, Mary [2 ]
Leher, Henry [2 ]
机构：
[1] Boston Univ, Sch Med, Boston, MA USA
[2] Aurinia Pharmaceut Inc, Victoria, BC, Canada
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2022年 / 33卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
FR-OR58
引用
收藏
页码：33 / 33
页数：1
相关论文
共 50 条
  • [21] AURORA PHASE 3 STUDY DEMONSTRATES VOCLOSPORIN STATISTICAL SUPERIORITY OVER STANDARD OF CARE IN LUPUS NEPHRITIS (LN)
    Arriens, C.
    Polyakova, S.
    Adzerikho, I.
    Randhawa, S.
    Solomons, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 172 - 173
  • [22] AURORA PHASE 3 TRIAL DEMONSTRATES VOCLOSPORIN STATISTICAL SUPERIORITY OVER STANDARD OF CARE IN LUPUS NEPHRITIS (LN)
    Gibson, Keisha
    Parikh, Samir
    Saxena, Amit
    Solomons, Neil
    Randhawa, Simrat
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2020, 75 (05) : 819 - 819
  • [23] AURORA PHASE 3 TRIAL DEMONSTRATES VOCLOSPORIN STATISTICAL SUPERIORITY OVER STANDARD OF CARE IN LUPUS NEPHRITIS (LN)
    Caster, Dawn J.
    Solomons, Neil
    Randhawa, Simrat
    Huizinga, Robert B.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 119 - 119
  • [24] The Cost-Effectiveness of Belimumab and Voclosporin for Patients with Lupus Nephritis in the United States
    Mandrik, Olena
    Fotheringham, James
    Ren, Shijie
    Tice, Jeffrey A.
    Chapman, Richard H.
    Stevenson, Matthew D.
    Pearson, Steven D.
    Herron-Smith, Serina
    Agboola, Foluso
    Thokala, Praveen
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 17 (03): : 385 - 394
  • [25] Efficacy and safety of tacrolimus for induction therapy in patients with active lupus nephritis
    Takahashi, Satoshi
    Hiromura, Keiju
    Sakurai, Noriyuki
    Matsumoto, Takayuki
    Ikeuchi, Hidekazu
    Maeshima, Akito
    Kaneko, Yoriaki
    Kuroiwa, Takashi
    Nojima, Yoshihisa
    MODERN RHEUMATOLOGY, 2011, 21 (03) : 282 - 289
  • [26] Clinical efficacy and safety of rituximab in lupus nephritis
    Zhong, Zhiqing
    Li, Hongyan
    Zhong, Hongzhen
    Zhou, Tianbiao
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 13 : 845 - 856
  • [27] THE EFFICACY OF VOCLOSPORIN IN LUPUS NEPHRITIS IS INDEPENDENT OF CHANGES IN ANTI-DSDNA AND COMPLEMENT AT WEEK 52
    Diamond, Betty
    Truman, Matt
    Mina-Osorio, Paola
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2022, 79 (04) : S2 - S2
  • [28] A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis
    Rovin, Brad H.
    Solomons, Neil
    Pendergraft, William F., III
    Dooley, Mary Anne
    Tumlin, James
    Romero-Diaz, Juanita
    Lysenko, Lidia
    Navarra, Sandra V.
    Huizinga, Robert B.
    KIDNEY INTERNATIONAL, 2019, 95 (01) : 219 - 231
  • [29] Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
    Rovin, Brad H.
    Teng, Y. K. Onno
    Ginzler, Ellen M.
    Arriens, Cristina
    Caster, Dawn J.
    Romero-Diaz, Juanita
    Gibson, Keisha
    Kaplan, Joshua
    Lisk, Laura
    Navarra, Sandra
    Parikh, Samir V.
    Randhawa, Simrat
    Solomons, Neil
    Huizinga, Robert B.
    LANCET, 2021, 397 (10289): : 2070 - 2080
  • [30] VOCLOSPORIN INCREASES RENAL RESPONSE AT COMMONLY USED UPCR THRESHOLDS IN PATIENTS WITH LUPUS NEPHRITIS
    Dall'Era, Maria
    Mina-Osorio, Paola
    Birardi, Vanessa
    Randhawa, Simrat
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36
12345